Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Siva, Sivappriyan"'
Autor:
null Benjamin C. T. Field, null Yue Ruan, null Kinga A. Várnai, null Jim Davies, null Robert E. J. Ryder, null Rajiv Gandhi, null Sophie Harris, null Dinesh Nagi, null Dipesh Patel, null Punith Kempegowda, null Sarah H. Wild, null Emma G. Wilmot, null Kamlesh Khunti, null Rustam Rea, null Parth Narendran, null Amy Edwards, null Susan Gelding, null Kirun Gunganah, null Pyei Aung, null Moulinath Banerjee, null Ali Chakera, null Dominique Rouse, null Syed Haris Ahmed, null Ho Yee Cheung, null Hywel Roberts, null Susan Seal, null Syed Saah Shah, null Amir Hayat, null Cynthia Mohandas, null Htet Htet Aung, null Su Khant Chel, null Nyan Lin, null Kavitia Narula, null Furruq Quadri, null Su Lei Yin, null Yin Yin, null Alamin Alkundi, null Abdelmajid Musa, null Emma Birbeck, null Charles Bodmer, null Irene Bossman, null Sathis Kumar, null Umesh Dashora, null Elizabeth Toubi, null Mansoor Zafar, null Vinod Patel, null Amitha Gopinath, null Belinda Allan, null Remat Karim, null Raphael Levy, null Maia Aquino, null Ayesha Rahman, null Susan Baxter, null Malgorzata Adamus, null Kevin Baynes, null Siva Sivappriyan, null Ryan D’Costa, null Vernon Parfitt, null Mazharul Islam, null Sadia Nasir, null Gail Roadknight, null Kinga Várnai, null Senthil Vasan, null Vilashini Arul Devah, null Foteini Kavvoura, null Lina Ficken, null James Gilham, null Vincent Simpson, null Neil Walker, null Umaira Aziz, null Efthimia Karra, null Miranda Rosenthal, null Tracy Curran, null Angela Paisley, null Melissa Cull, null Parijat De, null Robert Ryder, null Priscilla Sarkar, null James Clark, null Jamie‐Leigh Williamson, null Younes R Younes, null Vesna Hogan, null Lauren Jackson, null Ben Field, null Lucy Robin, null Lydia Grixti, null Suann Tee, null Abilash Sathya, null Emma Wilmot, null Mayank Patel, null Catherine Holmes, null Wasim Hanif, null Sandip Ghosh, null Ehtasham Ahmad, null Ejaz Ahmed, null Melanie Davies, null Steven Hartshorn, null Lee Simons, null David Webb, null Ben Maylor, null Oliver Freeman, null Steve Harris, null Anupam Brahma, null Seshadri Pramodh, null Katy Frew, null Alison Mackenzie, null Abigail Wild, null Helen Casey, null Deborah Morrison, null Conor McKeag, null Anne Sillars, null Angus Stirling, null Fiona Smeeton, null Syed Muhammad, null Kofi Obuobie, null Win Yin, null Neera Agarwal, null Mike Atkinson, null Sai Ambati, null Rahim Khan, null Preethi Nalla, null Arshiya Tabasum, null Stamatios Zouras, null Akhila Mallipedhi, null Richard Chudleigh, null David Williams, null the ABCD COVID‐19 audit group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a2ede905469809d00b6f655bd5e1b4
https://doi.org/10.1111/dom.15076/v2/response1
https://doi.org/10.1111/dom.15076/v2/response1
Autor:
Thomas S J, Crabtree, Karen, Adamson, Hazel, Reid, Dennis, Barnes, Siva, Sivappriyan, Alex, Bickerton, Ian W, Gallen, Benjamin C T, Field, Iskandar, Idris, Robert E J, Ryder
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1398-1401
The ABCD semaglutide audit was designed to capture the routine clinical outcomes of people commenced on semaglutide in the UK. Previous work showed differential reductions in HbA1c and weight dependent on previous glucagon-like peptide-1 receptor ago
Autor:
Dennis Barnes, Anurita Rohilla, Alex Bickerton, Robert Ej Ryder, Rajeev Raghavan, Abcd Empagliflozin Audit Contributors, Suzanne Phillips, Devesh Sennik, Ian W. Gallen, Alison Evans, Siva Sivappriyan, Jackie Elliott, Thomas Sj Crabtree
Publikováno v:
British Journal of Diabetes. 21:62-66
Introduction: Evidence from phase III and the EMPA-REG OUTCOME trials have demonstrated improvements in renal endpoints with empagliflozin use. The EMPA-KIDNEY trial is currently underway and is assessing whether there are benefits of empagliflozin i
Autor:
THOMAS S.J. CRABTREE, ALISON GALLAGHER, SIVA SIVAPPRIYAN, KETAN DHATARIYA, RAJEEV P. RAGHAVAN, ALEX BICKERTON, JACKIE ELLIOTT, MELISSA L. CULL, GERRY RAYMAN, IAN W. GALLEN, ISKANDAR R. IDRIS, ROBERT E. RYDER
Publikováno v:
Diabetes. 71
SGLT2i treatment is associated with weight and Hba1c reduction. Previous work has demonstrated clinical predictors of HbA1c and weight reduction with canagliflozin. We aim to analyse predictors of HbA1c and weight change across the class. Methods: Pe
Autor:
THOMAS S.J. CRABTREE, DEVESH K. SENNIK, ALEX BICKERTON, DENNIS BARNES, SIVA SIVAPPRIYAN, KAREN ADAMSON, SUZANNE M. PHILLIPS, ALISON EVANS, NIELS LARSEN, AVINASH PANESAR, MELISSA L. CULL, IAN W. GALLEN, ISKANDAR R. IDRIS, ROBERT E. RYDER
Publikováno v:
Diabetes. 71
Obesity and type 2 diabetes are important drivers for the development of nonalcoholic fatty liver disease (NAFLD) . Glucagon-like peptide-1 receptor agonists (GLP1RAs) are efficacious for these conditions, but their potential as treatments for NAFLD
Autor:
Malik Mohammad Farhan, Siva Sivappriyan, Jesse Kumar, Samantha Anandappa, Maliha Iqbal, Maha Khalid
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Autor:
Thomas Sj Crabtree, Devesh K. Sennik, Anurita Rohilla, Melissa L. Cull, Robert E.J. Ryder, Ian W. Gallen, Karen Adamson, Siva Sivappriyan, Alex Bickerton, Dennis Barnes
Publikováno v:
Diabetes. 70
In January 2019, the ABCD nationwide semaglutide audit was launched with the aim of providing real world evidence on semaglutide use in UK clinical practice. Methods: Data were extracted from the ABCD audit tools and included providing they had suffi
Publikováno v:
Endocrine Abstracts.